Stock Taper
SCREENER COMPARE ANY 2 STOCKS
GHRS
GH RESEARCH PLC
NASDAQ
$28.23
▲ UP 1.11% (0.31)

KEY STATISTICS

Market Cap$1.94 B
52w High$31.44
52w Low$11.83
Dividend Yield—
Frequency—
P/E-28.23
Volume78.10K
Shares Out.68.56M

COMPANY

LEADERSHIP

Velichka Valcheva
CHIEF EXECUTIVE
Velichka Valcheva

ABOUT

SECTOR
Healthcare
WENT PUBLIC
June 25, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
73

PRICE TARGET

Target High$65.00
Target Low$39.00
Target Median$42.00
Target Consensus$48.83

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.—
NOV
5
THU

PRICE

$28.23 ▲ UP 1.11% (+$0.31)
$27.50$27.75$28.00$28.259:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM28.23

About GH Research PLC

https://www.ghres.com ↗

GH Research PLC is a Dublin-based biopharmaceutical company developing 5-MeO-DMT therapies, including GH001, for treatment-resistant depression and other psychiatric and neurological disorders.

INDUSTRY

Biotechnology

A PRODUCT GH RESEARCH PLC IS KNOWN FOR

GH001
GH001

GH001 is a clinical-stage inhalable mebufotenin (5-MeO-DMT) product targeting treatment-resistant depression and other psychiatric and neurological disorders.

COMPETITORS

COMPETITOR
ATAI COMPARE
CMPS COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
17
LISTED HERE
8
RANKED BY POSITION SIZE
IBB
0.09% · 362.9K
PSIL
4.55% · 90.1K
BBC
0.82% · 14.9K
GWX
0.03% · 11.3K
IBBQ
0.12% · 4.3K
GERD.L
0.00% · 2.9K
BIB
0.06% · 2.4K
FPXE
0.33% · 575

INSTITUTIONAL OWNERSHIP

SHARES OWNED
69.33%
HOLDERS
75
TOP 12 OF 75 · RANKED BY POSITION SIZE
Lynx1 Capital Management LP
10.8M sh · $151.33M
Bvf Inc/Il
8.8M sh · $112.11M
Ra Capital Management, L.P.
7.7M sh · $107.93M
Rtw Investments, LP
5.9M sh · $83.43M
Fmr LLC
5.3M sh · $76.18M
Cormorant Asset Management, LP
1.9M sh · $27.41M
Avoro Capital Advisors LLC
1.8M sh · $25.31M
Toronto Dominion Bank
1.4M sh · $19.65M
Deep Track Capital, LP
1.3M sh · $17.88M
Troluce Capital Advisors LLC
990.5K sh · $13.93M
Millennium Management LLC
937.9K sh · $13.19M
Jefferies Financial Group Inc.
712.3K sh · $10.01M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity5
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR
Forer Michael
Purchase · 100.0K shares
2026-08-11
★
DIRECTOR
Moore Duncan
Purchase · 2.2K shares
2026-08-11
★
DIRECTOR
Hanley Dermot John
Purchase · 2.2K shares
2026-08-11
★
DIRECTOR
Forer Michael
Purchase · 2.2K shares
2026-08-11

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
OVERWEIGHT 1
MARKET OUTPERFORM 1
OUTPERFORM 1
7 GRADES IN THE LAST 12 MONTHS
Cantor Fitzgerald OVERWEIGHT Guggenheim BUY Needham BUY HC Wainwright & Co. BUY Citizens MARKET OUTPERFORM RBC Capital OUTPERFORM Canaccord Genuity BUY

SECTORS PEERS

PEERPRICE
PVLA$155.70COMPARE
NBTX$38.99COMPARE
TYRA$28.61COMPARE
KURA$13.14COMPARE
SVRA$5.36COMPARE
ABUS$5.14COMPARE
SPRY$5.63COMPARE
RZLT$4.61COMPARE